FDANonrulemakingFDA-2024-D-1461

Who commented on this docket

Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Content and Format of Composition Statement and Corresponding Statement of Ingredients in Labeling in NDAs and ANDAs; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 760d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 760d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.